ClariVest Asset Management LLC raised its stake in UnitedHealth Group Inc. (NYSE:UNH) by 0.1% during the second quarter, Holdings Channel reports. The firm owned 350,075 shares of the healthcare conglomerate’s stock after buying an additional 381 shares during the period. UnitedHealth Group accounts for approximately 1.5% of ClariVest Asset Management LLC’s portfolio, making the stock its 13th largest position. ClariVest Asset Management LLC’s holdings in UnitedHealth Group were worth $49,430,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of Montreal Can acquired a new position in shares of UnitedHealth Group during the second quarter valued at approximately $207,013,000. Dodge & Cox increased its stake in UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares in the last quarter. Prudential Financial Inc. increased its stake in UnitedHealth Group by 47.4% in the first quarter. Prudential Financial Inc. now owns 2,458,710 shares of the healthcare conglomerate’s stock valued at $316,927,000 after buying an additional 790,220 shares in the last quarter. NN Investment Partners Holdings N.V. purchased a new stake in UnitedHealth Group during the first quarter valued at about $83,434,000. Finally, UBS Asset Management Americas Inc. increased its stake in UnitedHealth Group by 13.0% in the first quarter. UBS Asset Management Americas Inc. now owns 4,424,657 shares of the healthcare conglomerate’s stock valued at $570,338,000 after buying an additional 508,995 shares in the last quarter. Institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 0.14% on Friday, hitting $136.66. 2,568,703 shares of the stock traded hands. The stock has a 50 day moving average of $137.80 and a 200-day moving average of $136.35. The stock has a market cap of $130.15 billion, a PE ratio of 21.39 and a beta of 0.57. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. On average, equities research analysts expect that UnitedHealth Group Inc. will post $7.90 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were given a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.83%. UnitedHealth Group’s dividend payout ratio is 39.12%.
Several analysts recently issued reports on the stock. Leerink Swann reaffirmed an “outperform” rating and set a $165.00 price objective (up from $155.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. FBR & Co reaffirmed an “outperform” rating and set a $155.00 price objective (up from $145.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a report on Friday, July 22nd. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and set a $161.00 price objective (up from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Finally, Credit Suisse Group AG reaffirmed a “buy” rating and set a $155.00 price objective (up from $148.00) on shares of UnitedHealth Group in a report on Wednesday, July 20th. One investment analyst has rated the stock with a hold rating, twenty-five have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.